We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

36 hedge funds and large institutions have $13.1M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

25% more capital invested

Capital invested by funds: $10.5M → $13.1M (+$2.62M)

16% less funds holding

Funds holding: 43 → 36 (-7)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
36
Holders Change
-7
Holders Change %
-16.28%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
4
Closed
15
Calls
$152K
Puts
–
Net Calls
+$152K
Net Calls Change
+$153K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$346K
2
CAM
ClariVest Asset Management
California
+$188K
3
EGA
Eagle Global Advisors
Texas
+$161K
4
BFA
BlackRock Fund Advisors
California
+$87.5K
5
BIT
BlackRock Institutional Trust
California
+$83.6K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$109K
2
AI
Ariel Investments
Illinois
-$102K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$39K
4
EAM
Evanson Asset Management
California
-$25K
5
SIM
Spark Investment Management
New York
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$13K – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$9K +$7.72K +6 New
Citigroup
28
Citigroup
New York
$8K -$21.9K -17 -74%
WEC
29
Winslow Evans & Crocker
Massachusetts
$7.16K – – –
BIM
30
BlackRock Investment Management
Delaware
$7K +$6.43K +5 New
Simplex Trading
31
Simplex Trading
Illinois
$6K +$5.14K +4 New
First Manhattan
32
First Manhattan
New York
$3K – – –
Group One Trading
33
Group One Trading
Illinois
$2K -$5.14K -4 -67%
UBS Group
34
UBS Group
Switzerland
$2K – – –
Morgan Stanley
35
Morgan Stanley
New York
$1K – – –
PAM
36
Panagora Asset Management
Massachusetts
$1K – – –
Two Sigma Advisers
37
Two Sigma Advisers
New York
– -$39K -32 Closed
SIM
38
Spark Investment Management
New York
– -$25K -21 Closed
EAM
39
Evanson Asset Management
California
– -$25K -20 Closed
CCM
40
Coldstream Capital Management
Washington
– -$20K -16 Closed
BMM
41
Berkshire Money Management
Massachusetts
– -$15K -12 Closed
RJFSA
42
Raymond James Financial Services Advisors
Florida
– -$14K -12 Closed
State Street
43
State Street
Massachusetts
– -$14K -12 Closed
Charles Schwab
44
Charles Schwab
California
– -$14K -11 Closed
CCMH
45
Cornerstone Capital Management Holdings
New York
– -$13K -11 Closed
TSS
46
Two Sigma Securities
New York
– -$8K -6 Closed
PPSG
47
Princeton Portfolio Strategies Group
New Jersey
– -$7K -5 Closed
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
– -$5K -4 Closed
BMO
49
Beck Mack & Oliver
New York
– -$5K -4 Closed
Two Sigma Investments
50
Two Sigma Investments
New York
– -$5K -4 Closed
1
2
3

FRTX Hedge Fund Activity: Q2 2016 in Review

36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2016, worth a combined $13.1M — up 25% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of FRTX and 9 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, adding an estimated $346K. The largest seller was Fidelity Investments, cutting an estimated $109K.

  • 36 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2016, down from 43 in Q1 2016.
  • Funds reported $13.1M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2016, up 25% quarter-over-quarter.
  • 9 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2016 and 15 closed out, a net change of -6 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2016 was Renaissance Technologies, an estimated $346K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2016 was Fidelity Investments, an estimated $109K sold.

Based on aggregated 13F filings for Q2 2016.